The Startle Disease Mutation Q266H, in the Second Transmembrane Domain of the Human Glycine Receptor, Impairs Channel Gating

  • Andrew J. Moorhouse, Patrice Jacques, Peter H. Barry, Peter R. Schofield
  • Molecular Pharmacology, February 1999, American Society for Pharmacology & Experimental Therapeutics (ASPET)
  • DOI: 10.1124/mol.55.2.386

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1124/mol.55.2.386